NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Company News » Quanterix gets FDA EUA status for Simoa SARS-CoV-2 N protein antigen test » Quanterix

Quanterix gets FDA EUA status for Simoa SARS-CoV-2 N protein antigen test

NS Medical Devices is using cookies

The EUA enables the SARS-CoV-2 N protein antigen test to use with nasopharyngeal samples. (Credit: visuals3Dde from Pixabay)

Related Article

CES 2021: Five of the best medical technologies from this year’s innovation trade show

RECOMMENDED COMPANIES

MOST READ

CES 2021: Five of the best medical technologies from this year’s innovation trade show

How could medical device regulation change under president-elect Biden?

Four breakthrough medical devices that could help to treat Alzheimer’s in the future

Could a tiny LED microchip device be a future medical treatment for obesity?

How a hip prosthesis for dogs could be used to improve quality of life in human patients

Recommended Whitepaper